MIR3135A: A Potential Drug Target and Biomarker (G100422901)
MIR3135A: A Potential Drug Target and Biomarker
MIR3135A is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is melanoma-associated protein 3135A, and it has been identified as a potential drug target and biomarker for various diseases, including cancer.
The discovery of MIR3135A as a potential drug target comes from a study by researchers at the University of California, San Diego, who found that the protein was highly expressed in various types of cancer, including melanoma, breast cancer, and prostate cancer. The researchers also found that MIR3135A was involved in cell signaling pathways that are often associated with cancer growth and progression.
Furthermore, MIR3135A has also been shown to be a potential biomarker for various types of cancer, including melanoma. Researchers have found that higher levels of MIR3135A are associated with a higher risk of melanoma, and that the protein appears to be involved in the development and progression of this disease.
The identification of MIR3135A as a potential drug target and biomarker has significant implications for the development of new treatments for various types of cancer. By targeting MIR3135A with drugs, researchers hope to inhibit its role in cancer growth and progression and potentially slow down or even reverse the disease.
In addition, the study of MIR3135A has also identified new potential biomarkers for cancer. By detecting the protein in individuals who have cancer, researchers hope to use MIR3135A as a diagnostic tool for cancer and to identify individuals who are at risk for the disease.
Overall, the discovery of MIR3135A as a potential drug target and biomarker for cancer has significant implications for the development of new treatments for this disease. Further research is needed to fully understand its role and to develop safe and effective treatments.
Protein Name: MicroRNA 3135a
The "MIR3135A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3135A comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328
